Urothelial tumorigenesis: a tale of divergent path...[Nat Rev Cancer. 2005]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Nat Rev Cancer. 2005 Sep;5(9):713-25. Links

Urothelial tumorigenesis: a tale of divergent pathways.

Wu XR.

Department of Urology, New York University School of Medicine, New York, New York 10016, USA. xue-ru.wu@med.nyu.edu

Urothelial carcinoma of the bladder is unique among epithelial carcinomas in its divergent pathways of tumorigenesis. Low-grade papillary tumours rarely become muscle-invasive and they frequently harbour gene mutations that constitutively activate the receptor tyrosine kinase-Ras pathway. By contrast, most high-grade invasive tumours progress to life-threatening metastases and have defects in the p53 and the retinoblastoma protein pathways. Correcting pathway-specific defects represents an attractive strategy for the molecular therapy of urothelial carcinomas.

PMID: 16110317 [PubMed - indexed for MEDLINE]

Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. [Cancer Res. 1999]
Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. [Oncogene. 2001]
Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma. [Arch Pathol Lab Med. 2005]
Review[Urothelial cancers. Cytogenetic and molecular biology principles] [Urologe A. 1994]
Review[Molecular changes in development and progression of urothelial carcinoma] [Verh Dtsch Ges Pathol. 2003]

Display Show

Urothelial tumorigenesis: a tale of divergent pathways.

Related Articles